In conjunction, PeptiENV is expected to improve the therapeutic response to enveloped
oncolytic viruses in the treatment of multiple forms of cancer.
Valo Therapeutics Limited, an immuno-oncology company developing tumour antigen-coated
oncolytic viruses as therapeutic vaccines, has licensed proprietary PeptiENVTM technology from Helsinki University, it was reported yesterday.
Release date- 29082019 - SAN DIEGO - Calidi Biotherapeutics Inc., a clinical stage biotechnology company at the forefront of
oncolytic virus-based immunotherapies for cancer announced today, the completion of the adipose tissue collection from healthy donors necessary for isolation of adipose-derived mesenchymal stem cells (AD-MSC) carriers and potentiators of
oncolytic viruses.
M2 PRESSWIRE-August 27, 2019-: Creative Biolabs Provides Standardized and High-quality Pre-made
Oncolytic Virus for Global Clients
Australian immuno-oncology company Imugene Ltd (ASX: IMU) will acquire Vaxinia Pty Ltd and separately acquire a worldwide exclusive licence to a promising
oncolytic virus technology, known as CF33, developed at US-based research and treatment centre City of Hope, the company said.
One type of virus in particular -
oncolytic viruses - can kill tumour cells.
Mustang Bio and Nationwide Children's Hospital announced that they have partnered and entered into an exclusive worldwide license agreement to develop an
oncolytic virus, or C134, for the treatment of glioblastoma multiforme.
Oncolytic viruses have the power of directly lysing cancer cells, and they also free tumor-specific neoantigents, as they can indirectly act as a cancer vaccine.
Transgene and Randox have entered into a collaboration to combine their technologies and develop multifunctional
oncolytic immunotherapies.
"Our results are the first to provide insight into ways of targeting multiple brain metastatic deposits with stem cell-loaded
oncolytic viruses that specifically kill dividing tumor cells."
Oncolytic therapy proposes a fundamental shift in cancer treatments, potentially changing the demographics of mortality due to cancers and its incidences and may ensure provision of a treatment that is safer and less terrifying.